Elevated serum DAND5 is associated with metastasis and predicts poor prognosis in colorectal cancer

The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer

(2016) Yayun Chi et al.   Oncotarget

RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer

(2015) Hiroki Imaoka et al.   CARCINOGENESIS

Coco is a dual activity modulator of TGFβ signaling

(2015) Alessia Deglincerti et al.   DEVELOPMENT

Elevated Serum Angiopoietin-like Protein 2 Correlates with the Metastatic Properties of Colorectal Cancer: A Serum Biomarker for Early Diagnosis and Recurrence

(2014) Y. Toiyama et al.   CLINICAL CANCER RESEARCH

Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer

(2014) Xin-Juan Fan et al.   TUMOR BIOLOGY

Coco regulates dorsoventral specification of germ layers via inhibition of TGF  signalling

(2013) T. J. D. Bates et al.   DEVELOPMENT

The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites

(2012) Hua Gao et al.   CELL

Prognostic factors after resection of colorectal liver metastases: from morphology to biology

(2012) Dario Ribero et al.   Future Oncology

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

(2012) David A. Lieberman et al.   GASTROENTEROLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma

(2010) Jie Xu et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial

(2008) K. Koyanagi et al.   CLINICAL CANCER RESEARCH